S100A8 and cholangiocarcinoma: S100A8 can activate the Toll-like receptor 4 (TLR4)-NF-κB signaling pathway, which upregulates VEGF expression, and thus, leads to the invasion and metastasis of cholangiocarcinoma cells 29.